跳至主要内容
临床试验/CTRI/2012/08/002925
CTRI/2012/08/002925已完成4 期

Glycemic control and quality of life in children, adolescents and young adults with type-1 diabetes mellitus described in a world-wide cross-sectional study in 2012: Impact of age-patient-related, treatment-related, behavior and structure of care-related variables. - TEENs

Sanofi Synthelabo India Limited0 个研究点目标入组 5,000 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
5,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients aged > 8 to < 25 years old, diagnosed at least 1 year prior to
  • the study entry with type-1 diabetes mellitus.
  • 2. Signed written informed consent obtained from the patient if
  • applicable or from the parent(s)/guardian.

排除标准

  • 1. T1DM diagnosed after 18 years of age for patients 18 years old.
  • 2. Diabetes other than type-1 diabetes (e.g. type-2 diabetes, secondary
  • diabetes mellitus (pancreatic history, drug- or chemical-induced
  • diabetes), genetic defects in β-cell function or insulin action).
  • 3. Use of systemic glucocorticoids (excluding topical application or
  • inhaled forms) for 7 consecutive days or more within the last 3
  • 4. Patients with known uncontrolled or inadequately controlled
  • hyperthyroidism or hypothyroidism.
  • 5. Change from pump regimen to multiple insulin injections regimen
  • within the last 3 months.
  • 6. Change from multiple insulin injections regimen to pump regimen
  • within the last 3 months.
  • 7. Treatment with oral antidiabetic drugs (OAD) (except metformin
  • which is permitted) at any time from the diagnosis.
  • 8. Treatment with any investigational drug within the last 3 months.
  • 9. Any known medical condition impacting red blood cells production
  • or destruction such as hemoglobinopathy, polycythemia, splenectomy,
  • iron deficiency anemia, hemorrhage, myelodysplastic disease or
  • receipt or donation of blood or plasma products within the last 3
  • 10. Patient or parent/legally authorized representative(s) unable to
  • understand the nature and scope of the study, unable to read and write
  • or unlikely to comply with the protocol, e.g. inability and
  • unwillingness to complete the questionnaires.
  • 11. Children or relatives of the Investigators, research assistants, study
  • coordinator or other staff directly involved in the conduct of the
  • protocol, employee of the Sponsor or of Sponsorâ??s representatives.

研究者

相似试验